Pengfengcheng Medical
鹏锋诚医疗
Pengfengcheng Medical
Biotech/Healthcare
Pengfengcheng Medical develops vision-screening devices for infants and young children. Following more than three years of laboratory and clinical research, the company applied computer and AI technologies to commercialize a clinical product based on optokinetic nystagmus (OKN) induction.
Latest round: Angel (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.